Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
DOI:
https://doi.org/10.26641/2307-0404.2018.4.152987Ключевые слова:
hypertension, gout, urat-lowering therapy, antihypertensive drugsАннотация
The prevalence of cardiovascular diseases, especially arterial hypertension, continues to increase. An important problem is the management of the patient with a comorbid pathology in the primary link by the family physician. The purpose of this study was to assess the state of medical care in patients with arterial hypertension combined with gout, using a retrospective analysis of ambulatory cards, diagnostic and treatment data. There were analyzed 105 outpatient cards that met the inclusion criteria. The mean age of patients was 53.5±10.2 years. Among the examined patients there were 99 males (94.3%), and 6 (5.7%)females. Аrterial hypertension stage II has been reported in 100 (95.2%) patients, stage III – 5 (4.8%) patients. Аrterial hypertension 1 degree is established in 74 (70,5%) patients, 2 degrees – 21 (20%), 3 degrees – 10 (9,5%). The average duration of the gout was 4.4 [4; 2] years, arterial hypertension – 5.3 [3; 1] years. Acute gouty arthritis was present in 11 (10.5%) patients, chronic gouty arthritis – 85 (81%), and chronic tofi arthritis – 9 (8.5%). Patients seek medical help from their family doctor too late. Examination of patients with hypertension in combination with gout is not complete, this contributes to underestimation of total cardiovascular risk. In a number of cases, titration of the dose of allopurinol higher than 300 mg is not, performed so only a third of patients reach the target uric acid level.Библиографические ссылки
Pan А, Teng GG, Yuan J-M, Koh W-P. Bidirectional Association between Self-Reported Hypertension and Gout: TheSingaporeChinese Health Study. PLoS ONE. 2015;10(10):e0141749. doi: 10.1371/journal.pone.0141749
Dehlin M, Jacobsson LTH. Trends in gout hospitalization inSweden. J. Rheumatol. 2018;45(1):145-6.
Ishida Т, Oh А, Hiroi S, et al. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities. Clin. Exp. Hypertens. 2018;1-8. doi: 10.1080/10641963.2018.146507
Boujnah R, Nazek L, Maalej М, et al. Hypertension in Tunisian adults attending primary care physicians (ETHNA-Tunisia). Indian Heart J. 2018;70(4):544-7.
Jeyaruban A, Larkins S, Soden M. Management of gout in general practice: a systematic review. J. Clin. Rheumatol. 2015;34:9-16.
Kiadaliri AA, Englund М. Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations inSweden, 1998-2015. Clin. Rheumatol. 2018;37(3):825-30.
Roddy Е, Packham J, Obrenovic К, et al. Management of gout by UKrheumatologists: a British Society for Rheumatology national audit. https://www.ncbi.nlm.nih.gov/pubmed/29447370">Rheumatology (Oxford). 2018;57(5):826-30.
Scheepers LEJM, Burden AM, Arts ICW, et al. Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology (Oxford). 2018;57(9):1641-50.
Muntner Р, Carey RM, Gidding S, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109-18.
Richette P, Doherty M, Pascual E. 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases; 2016. Available from: http://ard.bmj.com/content/early/2016/07/25/annrheumdis-2016-209707.full.pdf+html.
Edwards NL, Sunday JS, Forsuthe А, et al. Work productivity loss due to flares in patient with chronic gout refractory to conventional therapy. J. Med. Econ. 2011;14(1):10-15.
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
![Лицензия Creative Commons](http://i.creativecommons.org/l/by/4.0/88x31.png)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.